We are live on ! Find out more
OM icon

Outset Medical

Positive
Neutral
Negative
Sentiment 3-Months
Positive 13.3%
Neutral 80%
Negative 6.7%

Neutral
PRNewsWire
10 days ago
Outset Medical, Inc. (NASDAQ: OM) Investor Alert: Schubert Jonckheer Investigating Possible False Statements, Over $50 Million in Insider Sales
SAN FRANCISCO, July 6, 2026 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP advises Outset Medical, Inc. (NASDAQ: OM) investors that the firm is investigating potential legal claims arising from alleged false statements about FDA clearance requirements for one of the company's key products and demand for its dialysis machines. Current shareholders are encouraged to contact the firm here: https://www.classactionlawyers.com/outset.
Outset Medical, Inc. (NASDAQ: OM) Investor Alert: Schubert Jonckheer Investigating Possible False Statements, Over $50 Million in Insider Sales
Neutral
GlobeNewsWire
14 days ago
Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
SAN JOSE, Calif., July 02, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity (the “Company”), today announced that the Compensation Committee of its Board of Directors approved equity awards under the Company's Inducement Plan, as a material inducement to employment with the Company, for one recently hired executive employee and two recently hired non-executive employees, each of whom was not previously an employee or director of the Company.
Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Positive
Zacks Investment Research
28 days ago
Outset Medical (OM) Surges 25.6%: Is This an Indication of Further Gains?
Outset Medical (OM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Outset Medical (OM) Surges 25.6%: Is This an Indication of Further Gains?
Neutral
Business Wire
1 month ago
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 2026
GENEVA--(BUSINESS WIRE)--OM Pharma Unveils the Largest Multi-Country Real-World Evidence Study on Broncho Vaxom® (OM 85) for RTI Prevention at EAACI 2026.
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 2026
Neutral
GlobeNewsWire
1 month ago
Osisko Intersects 80 Metres Averaging 1.93% Cu at Gaspé
MONTREAL, June 09, 2026 (GLOBE NEWSWIRE) -- Osisko Metals Incorporated (the "Company" or "Osisko Metals") ( TSX: OM ; OTCQX: OMZNF ; FRANKFURT: 0B51 ) is pleased to announce initial results from the 2026 drill program at the Gaspé Copper Project, located in the Gaspé Peninsula of Eastern Québec. Five drills are currently active on the property, with two additional drills commencing work this month.
Osisko Intersects 80 Metres Averaging 1.93% Cu at Gaspé
Neutral
PRNewsWire
1 month ago
Did Outset Medical, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are urged to contact the firm immediately at no cost or obligation, as there may be limited time to enforce your rights.   We would handle the matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
Did Outset Medical, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Neutral
GlobeNewsWire
1 month ago
Osisko Metals Files NI 43-101 Technical Report for the Gaspé Copper Project
TORONTO, May 29, 2026 (GLOBE NEWSWIRE) -- Osisko Metals Incorporated (the "Company" or "Osisko Metals") (TSX: OM; OTCQX: OMZNF; FRANKFURT: OB51) is pleased to announce the filing on SEDAR+ of a technical report titled "NI 43-101 Technical Report on the Gaspé Copper Project with an Updated Mineral Resource Estimate for the Copper Mountain Deposit, Quebec, Canada" dated May 28, 2026 (with an effective date of January 17, 2026) (the "Technical Report"), in accordance with National Instrument 43-101 – Standards of Disclosure for Mineral Projects ("NI 43-101").
Osisko Metals Files NI 43-101 Technical Report for the Gaspé Copper Project
Neutral
GlobeNewsWire
1 month ago
Osisko Metals Announces Results of Voting at 2026 Annual Meeting of Shareholders and Welcomes Keith McKay to the Board
TORONTO, May 28, 2026 (GLOBE NEWSWIRE) -- Osisko Metals Incorporated (TSX:OM "Osisko" or the "Corporation") announces the results of its annual meeting of shareholders (the "Meeting") held earlier today. A total of 475,369,374 common shares of the Corporation were represented at the Meeting, representing approximately 64.4% of the total number of common shares of the Corporation issued and outstanding.
Osisko Metals Announces Results of Voting at 2026 Annual Meeting of Shareholders and Welcomes Keith McKay to the Board
Neutral
GlobeNewsWire
1 month ago
Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
SAN JOSE, Calif., May 21, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity (the “Company”), today announced that the Compensation Committee of its Board of Directors approved equity awards under the Company's Inducement Plan, as a material inducement to employment to two newly appointed non-executive employees, in each case, who were not previous employees or directors of the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4), which also requires a public announcement of any equity awards that are not made under a stockholder approved equity plan.
Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Neutral
GlobeNewsWire
2 months ago
Outset Medical to Present at RBC Global Healthcare Conference
SAN JOSE, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today announced that members of management will participate at the RBC Capital Markets Global Health Care conference on Tuesday, May 19, 2026, at 10:30 a.m.
Outset Medical to Present at RBC Global Healthcare Conference